LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1
Open Access
- 28 August 2020
- journal article
- research article
- Published by Springer Nature in Oncogenesis
- Vol. 9 (8) , 1-16
Abstract
Triple-negative breast cancer (TNBC) is a highly metastatic breast cancer subtype and due to the lack of hormone receptors and HER2 expression, TNBC has limited therapeutic options with chemotherapy being the primary choice for systemic therapy. LIM Domain Kinase 2 (LIMK2) is a serine/threonine kinase that plays an important role in the regulation of actin filament dynamics. Here, we show that LIM domain kinase 2 (LIMK2) is overexpressed in TNBC, and short-hairpin RNA (shRNA)-mediated LIMK2 knockdown or its pharmacological inhibition blocks metastatic attributes of TNBC cells. To determine the mechanism by which LIMK2 promotes TNBC metastatic progression, we performed stable isotope labeling by amino acids in cell culture (SILAC) based unbiased large-scale phosphoproteomics analysis. This analysis identified 258 proteins whose phosphorylation was significantly reduced due to LIMK2 inhibition. Among these proteins, we identified SRSF protein kinase 1 (SRPK1), which encodes for a serine/arginine protein kinase specific for the SR (serine/arginine-rich domain) family of splicing factors. We show that LIMK2 inhibition blocked SRPK1 phosphorylation and consequentially its activity. Furthermore, similar to LIMK2, genetic inhibition of SRPK1 by shRNAs or its pharmacological inhibition blocked the metastatic attributes of TNBC cells. Moreover, the pharmacological inhibition of LIMK2 blocked metastatic progression in mice without affecting primary tumor growth. In sum, these results identified LIMK2 as a facilitator of distal TNBC metastasis and a potential target for preventing TNBC metastatic progression.Keywords
This publication has 51 references indexed in Scilit:
- LIMK2 acts as an oncogene in bladder cancer and its functional SNP in the microRNA‐135a binding site affects bladder cancer riskInternational Journal of Cancer, 2018
- The influence of SRPK1 on glioma apoptosis, metastasis, and angiogenesis through the PI3K/Akt signaling pathway under normoxiaTumor Biology, 2015
- Triple-Negative Breast Cancer: Clinical Features and Patterns of RecurrenceClinical Cancer Research, 2007
- Genes that mediate breast cancer metastasis to lungNature, 2005
- The LIM domain: from the cytoskeleton to the nucleusNature Reviews Molecular Cell Biology, 2004
- Protein kinase CK2 phosphorylates and activates the SR protein-specific kinase 1Biochemical and Biophysical Research Communications, 2003
- Cofilin Phosphorylation and Actin Cytoskeletal Dynamics Regulated by Rho- and Cdc42-Activated Lim-Kinase 2Journal of Cell Biology, 1999
- Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganizationNature, 1998
- Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinaseNature, 1998
- SRPK1 and Clk/Sty Protein Kinases Show Distinct Substrate Specificities for Serine/Arginine-rich Splicing FactorsJournal of Biological Chemistry, 1996